Literature DB >> 24762829

IVIG pluripotency and the concept of Fc-sialylation: challenges to the scientist.

Stephan von Gunten1, Yehuda Shoenfeld2, Miri Blank2, Donald R Branch3, Tchavdar Vassilev4, Fabian Käsermann5, Jagadeesh Bayry6, Srini Kaveri6, Hans-Uwe Simon1.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 24762829     DOI： 10.1038/nri3401-c1

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN： 1474-1733            Impact factor:   53.106


× No keyword cloud information.
  29 in total

1.  Intravenous immunoglobulin exerts reciprocal regulation of Th1/Th17 cells and regulatory T cells in Guillain-Barré syndrome patients.

Authors:  Mohan S Maddur; Magalie Rabin; Pushpa Hegde; Francis Bolgert; Moneger Guy; Jean-Michel Vallat; Laurent Magy; Jagadeesh Bayry; Srini V Kaveri
Journal:  Immunol Res       Date:  2014-12       Impact factor: 2.829

2.  Anti-inflammatory activity of intravenous immunoglobulins protects against West Nile virus encephalitis.

Authors:  Ruchi Srivastava; Chandran Ramakrishna; Edouard Cantin
Journal:  J Gen Virol       Date:  2015-02-09       Impact factor: 3.891

3.  GM-CSF and IL-4 are not involved in IVIG-mediated amelioration of ITP in mice: a role for IL-11 cannot be ruled out.

Authors:  B J B Lewis; D Leontyev; A Neschadim; M Blacquiere; D R Branch
Journal:  Clin Exp Immunol       Date:  2018-09       Impact factor: 4.330

4.  Defective functions of polymorphonuclear neutrophils in patients with common variable immunodeficiency.

Authors:  Sarah Casulli; Hélène Coignard-Biehler; Karima Amazzough; Michka Shoai-Tehrani; Jagadeesh Bayry; Nizar Mahlaoui; Carole Elbim; Srini V Kaveri
Journal:  Immunol Res       Date:  2014-10       Impact factor: 2.829

5.  Protein-glycan interactions as targets of intravenous/subcutaneous immunoglobulin (IVIg/SCIg) preparations.

Authors:  S von Gunten
Journal:  Clin Exp Immunol       Date:  2014-12       Impact factor: 4.330

6.  Intravenous immunoglobulin suppresses the polarization of both classically and alternatively activated macrophages.

Authors:  Chaitrali Saha; Prathap Kothapalli; Veerupaxagouda Patil; Gundallahalli Bayyappa ManjunathaReddy; Srini V Kaveri; Jagadeesh Bayry
Journal:  Hum Vaccin Immunother       Date:  2019-05-07       Impact factor: 3.452

Review 7.  Intravenous immunoglobulin in neurology--mode of action and clinical efficacy.

Authors:  Jan D Lünemann; Falk Nimmerjahn; Marinos C Dalakas
Journal:  Nat Rev Neurol       Date:  2015-01-06       Impact factor: 42.937

Review 8.  IgG and leukocytes: Targets of immunomodulatory α2,6 sialic acids.

Authors:  Mark B Jones
Journal:  Cell Immunol       Date:  2018-03-31       Impact factor: 4.868

9.  The novel panel assay to define tumor-associated antigen-binding antibodies in patients with metastatic melanomas may have diagnostic value.

Authors:  Beatrix Kotlan; Gabriella Liszkay; Miri Blank; Orsolya Csuka; Timea Balatoni; Laszlo Toth; Klara Eles; Szabolcs Horvath; Gyorgy Naszados; Judit Olasz; Balazs Banky; Jozsef Toth; Maria Godeny; Francesco M Marincola; Miklos Kasler; Yehuda Shoenfeld
Journal:  Immunol Res       Date:  2015-02       Impact factor: 2.829

Review 10.  Cancer intelligence acquired (CIA): tumor glycosylation and sialylation codes dismantling antitumor defense.

Authors:  Kayluz Frias Boligan; Circe Mesa; Luis Enrique Fernandez; Stephan von Gunten
Journal:  Cell Mol Life Sci       Date:  2014-12-07       Impact factor: 9.261
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.